2024-03-18 - CD Munich - ASTELLAS INSTITUTE FOR REGENERATIVE MEDICINE v. Healios K.K et al. - UPC_CFI_75/2023
- Aktenzeichen:
- UPC_CFI_75/2023
- Datum:
- Spruchkörper:
- Court of First Instance - Munich (DE) Central Division - Section
- Art:
- Proceeding Order
- Parteien:
- ASTELLAS INSTITUTE FOR REGENERATIVE MEDICINE v. Healios K.K, Riken, Osaka University
Kernaussage: Companion order to UPC_CFI_80/2023 — interim-conference order in Astellas' revocation action against Healios / Riken / Osaka University concerning EP 3 056 563 (sister patent in the induced pluripotent stem-cell family).
2024-03-18 - CD Munich - ASTELLAS INSTITUTE FOR REGENERATIVE MEDICINE
v.
Healios K.K et al. - UPC_CFI_75/2023
routine
Companion order to UPC_CFI_80/2023 — interim-conference order in Astellas' revocation action against Healios / Riken / Osaka University concerning EP 3 056 563 (sister patent in the induced pluripotent stem-cell family). The Court admitted Claimant's second declaration D18 and granted Defendants a short-reply window until 11 April 2024 — length similar to Claimant's submissions, strictly in reply, possibly including a short rebuttal expert report. Value of proceedings under Rule 104(j) in conjunction with Rule 152.3 RoP was set at EUR 4 M, yielding a EUR 400,000 recoverable-cost ceiling under the AC scale (Art. 69 UPCA). The Court reiterated that only reasonable and proportionate costs are recoverable and that assessment requires itemised hours × role × task × rate information. Oral hearing confirmed for 25 June 2024 (one day scheduled, 27 June reserved for contingencies).